GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

Financiere de Tubize TUB.BR · EUR

Health Care · Euronext Brussels · 🇧🇪 Belgium

Compare

246.00

+2.50%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in EUR, from our data supplier.

FY2025

Net income

€93.2m

FY2016FY2025

Free cash flow

€91.8m

FY2016FY2025

Shareholders' equity

€1.89bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross profit−€859−€2.2m−€2.0m−€1.8m−€1.5m—€3,000€286.1m€267.1m€302,000
Research and development———€10,449——€592——€24
Operating income−€3.0m−€2.2m−€2.1m−€1.8m€381.3m€260.9m€284.9m€290.3m€271.7m−€6.4m
Net income€93.2m€90.1m€88.2m€85.2m€380.1m€260.5m€283.7m€285.2m€285.9m€181.2m
Diluted earnings per share2.092.021.981.918.545.856.366.406.424.06

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets€1.93bn€1.93bn€1.92bn€1.84bn€3.27bn€2.83bn€2.75bn€2.48bn€2.31bn€2.22bn
Cash and short-term investments€1.3m€1.4m€574,841€1.1m€15.9m€983,000€462,000€1.5m€1.5m€662,000
Total liabilities€48.6m€89.3m€123.7m€87.2m€20.9m€34.3m€87.5m€144.0m€195.7m€265.3m
Debt—€41.3m€79.2m€47.8m€20.0m€33.5m€86.5m€142.6m€192.1m€241.0m
Shareholders' equity€1.89bn€1.84bn€1.80bn€1.75bn€3.25bn€2.79bn€2.66bn€2.34bn€2.12bn€1.96bn
Shares outstanding45m45m45m45m45m45m45m45m45m45m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations€91.8m−€2.1m−€2.0m€174.2m−€1.2m−€2.1m−€1.1m€75.8m€73.0m€67.7m
Free cash flow€91.8m−€2.1m−€2.0m€174.2m−€1.2m−€2.1m−€1.1m€75.8m€73.0m€67.7m
Dividends paid−€46.3m−€43.2m−€38.3m−€33.4m−€30.3m−€27.6m−€24.9m−€24.1m−€23.2m−€22.3m

Financial ratios

Data as of 6 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Gross margin—-16771.1%—-22327.6%——100.0%99.3%98.1%100.0%——
Operating margin—-16866.4%—1043625.3%——9496000.0%-0.3%-0.4%-2105.0%——
Net margin—679673.6%—1044901.1%——9456800.0%98.9%105.0%59995.4%——
Return on equity4.9%4.9%4.9%4.9%11.7%9.3%——————
Return on assets4.8%4.7%4.6%4.6%11.6%9.2%——————
Revenue growth——————-100.0%5.9%90043.4%30100.0%-100.0%-5.6%
Earnings growth3.5%2.2%3.5%-77.6%45.9%-8.2%——————
Current ratio0.03x0.02x0.01x0.01x0.76x0.03x——————
Debt to equity—0.02x0.04x0.03x0.01x0.01x0.03x—————
Equity ratio97.5%95.4%93.6%95.3%99.4%98.8%——————
Interest coverage50.25x-0.90x-0.57x41.24x2302.85x480.55x——————
R&D as a share of sales———128.2%——19.7%——0.0%——
Buybacks as a share of market value0.0%0.0%0.0%0.0%0.0%0.2%——————

Growth per year

Compound annual rate

3 years5 years10 years
Operating income17.7%—17.5%
Net income3.1%-18.6%-7.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings99.870.336.237.010.614.110.09.510.014.6
Price to sales———————9.410.5—

Dividends and splits

Per share, in the currency the company pays

Paid for 36 years. Last went ex-dividend on 7 May 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year1.081.040.970.860.750.680.620.56
  • 2-for-1 split · 17 Jun 2005
  • 100-for-1 split · 26 Nov 1999

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.